BRISTOL-MYERS SQUIBB COMPANY;ROCHE INNOVATION CENTER COPENHAGEN A/S
发明人:
OLSON, RICHARD E.,ANDERSON, BRIAN R.,HAGEDORN, PETER,JENSEN, MARIANNE LERBECH,MCDONALD, IVAR M.,MERCER, STEPHEN E.
申请号：
CA3091789
公开号：
CA3091789A1
申请日:
2019.02.21
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The present disclosure relates to antisense oligonucleotides, which target CAMK2D mRNA in a cell, leading to reduced expression of CAMK2D protein. Reduction of CAMK2D protein expression is beneficial for the treatment of certain medical disorders, e.g., cardiovascular-related diseases or disorders.
